Sirolimus in Pediatric Renal Transplantation
Authors:
- 1 March 2005
- journal article
- Published by Elsevier in Transplantation Proceedings
- Vol. 37 (2) , 682-684
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Long-term improvement in renal function with sirolimus after early cyclosporine withdrawal in renal transplant recipients: 2-year results of the rapamune maintenance regimen study1 2Transplantation, 2003
- Kidney transplantation without calcineurin inhibitor drugs: a prospective, randomized trial of sirolimus versus cyclosporine1Transplantation, 2002
- RISK FACTORS FOR POSTTRANSPLANT LYMPHOPROLIFERATIVE DISORDER (PTLD) IN PEDIATRIC KIDNEY TRANSPLANTATION: A REPORT OF THE NORTH AMERICAN PEDIATRIC RENAL TRANSPLANT COOPERATIVE STUDY (NAPRTCS)1Transplantation, 2001
- Progression of renal damage in chronic rejectionKidney International, 2000
- Improved Graft Survival after Renal Transplantation in the United States, 1988 to 1996New England Journal of Medicine, 2000
- Nephrotoxicity of immunosuppressive drugs: Long-term consequences and challenges for the futureAmerican Journal of Kidney Diseases, 2000
- NEORAL MONITORING BY SIMPLIFIED SPARSE SAMPLING AREA UNDER THE CONCENTRATION-TIME CURVETransplantation, 1999
- Lymphoproliferative disease in childrenTransplantation Proceedings, 1999
- Rapamune® (RAPA, rapamycin, sirolimus): mechanism of action immunosuppressive effect results from blockade of signal transduction and inhibition of cell cycle progressionClinical Biochemistry, 1998
- Rapamycin (sirolimus, rapamune)Current Opinion in Nephrology and Hypertension, 1995